Related Experiment Videos
[Prader-Willi syndrome]
1Clinica Pediatrica III, Centro di Endocrinologia Infantile e dell'Adolescenza, IRCCS Istituto Scientifico H San Raffaele, Università degli Studi, Milano.
Insights
Prader-Willi syndrome (PWS) is a genetic disorder causing obesity and developmental issues. Early diagnosis via genetic testing and a multidisciplinary approach are key to managing PWS complications.
Area of Science:
- Genetics
- Endocrinology
- Developmental Pediatrics
Background:
- Prader-Willi syndrome (PWS) is the leading genetic cause of obesity.
- It presents with hypotonia, distinct facial features, growth issues, and cognitive impairments.
Purpose of the Study:
- To detail diagnostic methods for PWS.
- To outline clinical, metabolic, and endocrinological features.
- To identify common complications and management strategies.
Main Methods:
- Genetic testing, including methylation analysis, is crucial for confirming PWS.
- Diagnosis relies on identifying genetic alterations on chromosome 15q11-13.
- Clinical evaluation assesses physical, behavioral, and cognitive aspects.
Main Results:
- Methylation testing is the most reliable diagnostic method.
- PWS involves neonatal hypotonia, dysmorphic facies, acromicria, hypogonadism, stunted growth, obesity, behavioral disturbances, and cognitive impairment.
- Frequent complications are linked to obesity and hormonal imbalances.
Conclusions:
- Early diagnosis of PWS is essential for preventing severe obesity and associated health issues.
- A multidisciplinary approach is vital for comprehensive patient management.
- Understanding PWS features aids in timely intervention and improved outcomes.
Abstract:
Prader-Willi syndrome (PWS) is the most frequent cause of secondary obesity, characterized by neonatal hypotonia, dysmorphic facies, acromicria, hypogonadism, stunted growth, obesity, behavioural disturbances and cognitive impairment. Clinical diagnosis is confirmed by alteration of imprinted genes on the proximal long arm of chromosome 15 (15q11-13) for deletion, translocation, uniparental disomy for maternal chromosome 15 or imprinting center defect. Methylation test is the most reliable test for diagnosis. This issue explains diagnostic tests, clinical, metabolic, endocrinological features, and the most frequent complications observed in this syndrome. Precocious diagnosis and multidisciplinary approach allow in these patients to prevent the severe obesity and linked complications.